Repurposing type I–F CRISPR–Cas system as a transcriptional activation tool in human cells

Abstract

Class 1 type I CRISPR–Cas systems have not been as extensively developed for genome engineering as Class 2 systems. Here the authors modify the Type I–F CRISPR–Cas system for transcriptional activation of gene expression.